Industry News

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Australia gives go-ahead for OTC CBD products
Premium

16 December 2020

Australia’s Therapeutic Goods Administration (TGA) has now given the final go-ahead for certain low-dose cannabidiol (CBD) medicines to be sold without a prescription. However, the TGA has made a number of changes to its interim decision released in September 2020.

Read the full story

New Zealand sticks by pholcodine recommendation
Premium

16 December 2020

New Zealand’s Medicines Classification Committee (MCC) is sticking by its recommendation that pholcodine should be reverse-switched from pharmacy-only to pharmacist-only status. The MCC has also made recommendations on fexofenadine, flurbiprofen and ibuprofen.

Read the full story

Switzerland’s Zur Rose makes changes in Germany
Premium

15 December 2020

Switzerland’s Zur Rose Group has announced that Olaf Heinrich – chief executive officer of the DocMorris online pharmacy and head of its business in Germany – has left the company for “personal reasons”. The company has also just given DocMorris a new brand identity.

Read the full story